Skip to Main
- Next-Generation RNA Therapeutics for Polycystic Kidney Disease
- Avidity-Based Therapeutics for Protein Misfolding Disorders such as Alzheimer’s
- Drugging ADP-Ribosylation Pathways in Cancer and Neurodegeneration
- siRNA Therapeutics for Renal Cell Carcinoma
- Bleb-Septin Signaling as a Therapeutic Target in Metastatic Cancer
- Precision Viral Delivery Targeting Metastatic Cancer
- Small-Molecule Modulators of Circadian Biology
- Hormone-Sensing Virulence Blockers for Staphylococcus aureus
- Forward Genetic Screens for Next-Generation Immunotherapies
- Molecular Therapeutics for Heterotopic Ossification
- Next-Generation CAR-T Therapies for Solid Tumors
- Ribo-SNAP Technology to Control Ribosome Biogenesis to treat cancer and aging
- Mitochondrial Import Pathways: TOMM as a Therapeutic Frontier
- Patient-Derived Antibody Therapeutics for Neurodegeneration
- ASObiotic Precision Antibiotics for Drug-Resistant Infections
- Targeting Orm2–IL23R Signaling for Next-Generation IBD Therapy
- Targeting Stress-Induced tRNA Fragments (tiRNAs) for Next-Generation Therapeutics
- Immune Modulator Therapeutics for Nerve Regeneration
- Inherently Antimicrobial Bone Cement for Orthopedic Infections
- Microbiome-Derived Immunotherapies for Cancer and Autoimmune Disease
